From the Department of Biochemistry, Weill Cornell Medical College, New York (R.K.S., A.S.H., P.B., F.R.M.).
Department of Biochemistry, Microbiology, and Immunology (X.Z.), University of Ottawa, ON, Canada.
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):137-149. doi: 10.1161/ATVBAHA.118.312087.
Objective- During atherosclerosis, LDLs (low-density lipoproteins) accumulate in the arteries, where they become modified, aggregated, and retained. Such deposits of aggregated LDL (agLDL) can be recognized by macrophages, which attempt to digest and clear them. AgLDL catabolism promotes internalization of cholesterol and foam cell formation, which leads to the progression of atherosclerosis. Therapeutic blockade of this process may delay disease progression. When macrophages interact with agLDL in vitro, they form a novel extracellular, hydrolytic compartment-the lysosomal synapse (LS)-aided by local actin polymerization to digest agLDL. Here, we investigated the specific regulators involved in actin polymerization during the formation of the LS. Approach and Results- We demonstrate in vivo that atherosclerotic plaque macrophages contacting agLDL deposits polymerize actin and form a compartment strikingly similar to those made in vitro. Live cell imaging revealed that macrophage cortical F-actin depolymerization is required for actin polymerization to support the formation of the LS. This depolymerization is cofilin-1 dependent. Using siRNA-mediated silencing, pharmacological inhibition, genetic knockout, and stable overexpression, we elucidate key roles for Cdc42 Rho GTPase and GEF (guanine nucleotide exchange factor) Vav in promoting actin polymerization during the formation of the LS and exclude a role for Rac1. Conclusions- These results highlight critical roles for dynamic macrophage F-actin rearrangement and polymerization via cofilin-1, Vav, and Cdc42 in LS formation, catabolism of agLDL, and foam cell formation. These proteins might represent therapeutic targets to treat atherosclerotic disease.
目的- 在动脉粥样硬化过程中,LDL(低密度脂蛋白)在动脉中积聚,在那里它们发生修饰、聚集和滞留。这种聚集的 LDL(agLDL)的沉积物可以被巨噬细胞识别,巨噬细胞试图消化和清除它们。agLDL 的分解代谢促进胆固醇的内化和泡沫细胞的形成,从而导致动脉粥样硬化的进展。对此过程的治疗性阻断可能会延迟疾病进展。当巨噬细胞在体外与 agLDL 相互作用时,它们形成一个新的细胞外水解隔室-溶酶体突触(LS),这是由局部肌动蛋白聚合辅助的,以消化 agLDL。在这里,我们研究了 LS 形成过程中肌动蛋白聚合所涉及的特定调节剂。方法和结果- 我们体内证明与 agLDL 沉积物接触的动脉粥样硬化斑块巨噬细胞聚合肌动蛋白并形成一个与体外形成的隔室非常相似的隔室。活细胞成像显示,巨噬细胞皮质 F-肌动蛋白解聚是肌动蛋白聚合以支持 LS 形成所必需的。这种解聚依赖于 cofilin-1。通过 siRNA 介导的沉默、药理学抑制、基因敲除和稳定过表达,我们阐明了 Cdc42 Rho GTPase 和 GEF(鸟嘌呤核苷酸交换因子)Vav 在促进 LS 形成过程中肌动蛋白聚合的关键作用,并排除了 Rac1 的作用。结论- 这些结果突出了巨噬细胞 F-肌动蛋白通过 cofilin-1、Vav 和 Cdc42 的动态重排和聚合在 LS 形成、agLDL 分解代谢和泡沫细胞形成中的关键作用。这些蛋白可能代表治疗动脉粥样硬化疾病的治疗靶点。